Paul Hastings Advised Viking Therapeutics on Its $632.5M Public Offering of Common Stock
March 05, 2024
March 05, 2024
LOS ANGELES, California, March 5 -- Paul Hastings, a law firm, issued the following news:
Paul Hastings LLP advised Viking Therapeutics, Inc. (Nasdaq: VKTX) in connection with the company's underwritten offering of $632.5 million of shares of its common stock. Morgan Stanley, Leerink Partners, William Blair, Raymond James, Stifel and Truist Securities acted as joint book-running managers for the offering, Oppenheimer & Co. acted as lead manager for the offering and BTIG, H. . . .
Paul Hastings LLP advised Viking Therapeutics, Inc. (Nasdaq: VKTX) in connection with the company's underwritten offering of $632.5 million of shares of its common stock. Morgan Stanley, Leerink Partners, William Blair, Raymond James, Stifel and Truist Securities acted as joint book-running managers for the offering, Oppenheimer & Co. acted as lead manager for the offering and BTIG, H. . . .